at 60 C for 30 min, to insure destruction of adenovirus, and diluted to 10-2; 2.0-ml volumes were inoculated on DK and HA cells (contained in 900-ml bottles). After 1 hr of incubation, inocula were removed, cultures were washed three times with Eagle's medium, and cells were inoculated with 2.0 ml of ICHV which contained 107.0 TCID50 per mnl. Inocula were again removed after 1 hr, cell cultures were washed three times with Eagle's medium, medium was replaced, and cultures were incubated at 36 C for 84 to 108 hr. Cultures were frozen-thawed; some inocula were removed for subpassage, and the remainder were stored at -20 C until needed. Material for subpassage was heated at 60 C for 5 min, and was inoculated (undiluted) on DK and HA cells (as before). Cells were then superinfected with ICHV, washed three times, and treated as before. AAV was thus serially subpassed three times, with fresh ICHV as "helper" each time, in DK and HA cells. Stored passages were later thawed, AAV particles were counted and titrated, and AAV CF antigen was measured by chessboard titration. Table 1 shows the results obtained from these serial passages in DK cells. Passages 1, 2, and 3 gave AAV particle increases of 200-, 78-, and 1.5-fold. Infectivity and CF assays gave similar results. The poor third passage in this series appears to be a technical error, since a repeat subpassage at this level gave about a 100-fold increase in infectious AAV. Table 2 shows the results obtained from three serial passages in HA cells. Particle increases were 1,125-, 14-, and 65-fold, respectively. Again, infectivity and CF antigen increases were of about the same order of magnitude as the particle increases. The particle-infectivity ratio of AAV in these passages (Tables 1 and 2 ) ranged from about 600 to 1,600. Approximately 5 x 109 to 2 X 1010 particles of AAV were required for minimal CF reaction, which is similar to our previous findings (K. 0. Smith et al., J. Immunol. 97:754, 1966 
tion), AAV type 1 (K. 0. Smith et al., J. Immunol. 97:754, 1966) , primary canine kidney (DK) cells, and human amnion (HA, strain FL) cells. AAV particles were counted (K. 0. Smith, Bacteriol. Proc., p. 130, 1964) , and AAV infectivity was titrated by a fluorescent-focus technique (J. F. Thiel and K. 0. Smith, Proc. Soc. Exptl. Biol. Med., in press); complement fixation (CF) tests were then performed (K. 0. Smith, J. Immunol. 94:976, 1965 Immunol. 97:754, 1966) .
AAV was serially passed in the following way. A virus suspension, containing approximately 1014 TCID50 per ml of adenovirus 4 and 108.0 fluorescing-focus units of AAV per ml, was heated at 60 C for 30 min, to insure destruction of adenovirus, and diluted to 10-2; 2.0-ml volumes were inoculated on DK and HA cells (contained in 900-ml bottles). After 1 hr of incubation, inocula were removed, cultures were washed three times with Eagle's medium, and cells were inoculated with 2.0 ml of ICHV which contained 107.0 TCID50 per mnl. Inocula were again removed after 1 hr, cell cultures were washed three times with Eagle's medium, medium was replaced, and cultures were incubated at 36 C for 84 to 108 hr. Cultures were frozen-thawed; some inocula were removed for subpassage, and the remainder were stored at -20 C until needed. Material for subpassage was heated at 60 C for 5 min, and was inoculated (undiluted) on DK and HA cells (as before). Cells were then superinfected with ICHV, washed three times, and treated as before. AAV was thus serially subpassed three times, with fresh ICHV as "helper" each time, in DK and HA cells. Stored passages were later thawed, AAV particles were counted and titrated, and AAV CF antigen was measured by chessboard titration. Table 1 shows the results obtained from these serial passages in DK cells. Passages 1, 2, and 3 gave AAV particle increases of 200-, 78-, and 1.5-fold. Infectivity and CF assays gave similar results. The poor third passage in this series appears to be a technical error, since a repeat subpassage at this level gave about a 100-fold increase in infectious AAV. Table 2 shows the results obtained from three serial passages in HA cells. Particle increases were 1,125-, 14-, and 65-fold, respectively. Again, infectivity and CF antigen increases were of about the same order of magnitude as the particle increases. The particle-infectivity ratio of AAV in these passages (Tables 1 and 2 ) ranged from about 600 to 1,600. Approximately 5 x 109 to 2 X 1010 particles of AAV were required for minimal CF reaction, which is similar to our previous findings (K. 0. Smith et al., J. Immunol. 97:754, 1966 493, 1938 ). An intrinsic error in these titrations, on the order of a:0.5 log unit, might be expected.
We found a 0.6-log increase on the first passage, a 2.5-log loss on second passage, and a 3.5-log loss on third passage. A second series of serial passages, employing an incubation time of 84 to 108 hr, gave somewhat more favorable yields (1.2-log increase on first passage and 0.2-log loss on second passage). These results contrast sharply with 48-hr harvests of ICHV-infected canine kidney cells (which allows for one growth cycle). Canine cells regularly gave 50-to 100-fold increases of ICHV over the original inocula. Inability of ICHV to replicate well in human amnion cells did not prevent it from potentiating AAV synthesis in these cells. Thus, it appears that some of the steps leading to the synthesis of large yields of infectious adenovirus particles are not required for AAV potentiation. Perhaps a cell-virus system such as this is deserving of further study as a means of determining the mechanism by which adenoviruses "help" AAV. These in vitro findings suggest that canine virushuman cell interactions in vivo, as well as human virus-canine cell interactions, might be considered.
